Status:
RECRUITING
Psychiatric Multi-omics and Neuroimaging Project
Lead Sponsor:
mingjun Zhong
Conditions:
Mental Disorders
Healthy Control
Eligibility:
All Genders
13-35 years
Brief Summary
This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patien...
Detailed Description
The study seeks to identify possible biological markers of schizophrenia and the effects of gene-environment interactions on brain structural and functional networks. So we can help doctors and scient...
Eligibility Criteria
Inclusion
- Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age)
- Course of disease: \<24 months
- Priority is given to patients who have never taken medicine or duration of drug use \< 2 weeks
- No nuclear magnetic contraindications.
Exclusion
- Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence
- Have a major physical disease or infectious disease
- History of coma and serious neurological disease 4.MRI contraindications.
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1899 Patients enrolled
Trial Details
Trial ID
NCT06580860
Start Date
January 1 2016
End Date
December 1 2025
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Xiangya hospital of central south univerity
Changsha, Hunan, China, 410000